Be Aware Canagliflozin Might Increase Amputation Risk in Diabetes Patients

A new boxed warning about amputation with canagliflozin (Invokana, etc) will raise more questions about the safety of SGLT2 inhibitors....

Get unlimited access through an Enterprise license

Hospital Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals